InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

I'm downgrading InMode from a 'Strong Buy' to a 'Buy' due to consistent guidance cuts and short-term demand issues. Despite recent performance issues and high interest rates, INMD still holds a strong ...

YOKNEAM, Israel, Oct. 9, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

On Tuesday, 18 March 2025, InMode Ltd (NASDAQ: INMD) presented at the Oppenheimer 35th Annual Health Care MedTech and Services Conference. The company addressed its strategies to overcome the current ...

Shares of InMode (NASDAQ: INMD), a medical technology company focused on the aesthetics industry, recently reached a new 52-week high in anticipation of the second-quarter earnings report the company ...

IRVINE, Calif., May 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, reports that the US District Court for the Central District of ...

On Wednesday, 04 June 2025, InMode Ltd (NASDAQ:INMD) participated in the Jefferies Global Healthcare Conference 2025, offering insights into its strategic direction amid challenging economic ...